If you made any changes in Pure these will be visible here soon.

Personal profile

Research Focus

I am a specialty registrar in Medical Microbiology, interested in new strategies to boost the immune response against complex pulmonary infections. The focus of my PhD is investigating the potential for mesenchymal stromal cells (MSCs) as a host-directed therapy for non-tuberculous mycobacterial infections, under the supervision of Prof Cecilia O'Kane, Dr Anna Krasnodembskaya and Dr Gunnar Schroeder.

Mesenchymal stromal cells (MSCs) are multipotent adult cells that regenerate injured tissues in normal health. Recent discoveries about their ability to modulate immune cell function has lead to their interest as a potential therapy for inflammation and infection.

I am studying MSC ability to enhance macrophages in the killing of non-tuberculous mycobacteria (NTM). These bacteria are resistant to most antibiotics and are a growing cause of pulmonary infection in patients with impaired immunity and structural lung disease. Today, the standard therapy for patients diagnosed with NTM pulmonary infection is a combination of three antibiotics taken for 12-18 months. The drugs can have severe side effects (such as kidney impairment and hearing loss) so that many patients cannot tolerate the full course, and even when treatment is tolerated success rates are under 60%. Therefore we urgently need new approaches to activate the immune response against NTM and enhance antibiotic clearance.

Fingerprint Dive into the research topics where Timothy Shaw is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Enterococcus faecium Medicine & Life Sciences
Glycopeptides Medicine & Life Sciences
Adult Respiratory Distress Syndrome Medicine & Life Sciences
Cystic Fibrosis Medicine & Life Sciences
Pseudomonas aeruginosa Medicine & Life Sciences
Disease Outbreaks Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2018

Research Output 2014 2019

3 Citations (Scopus)

Emerging drugs for treating the acute respiratory distress syndrome

Shaw, T. D., McAuley, D. F. & O'Kane, C. M., 18 Mar 2019, In : Expert opinion on emerging drugs. 24, 1, p. 29-41 13 p.

Research output: Contribution to journalReview article

Adult Respiratory Distress Syndrome
Pharmaceutical Preparations
Clinical Trials
Pharmacology
Expert Testimony
1 Citation (Scopus)
49 Downloads (Pure)
Open Access
File
Enterococcus faecium
Glycopeptides
Disease Outbreaks
Clone Cells
Genes

A putative novel mechanism of resistance to quinupristin-dalfopristin in clinical isolates of Enterococcus faecium in Northern Ireland

Shaw, T. D., Schneiders, T., Pathiraja, M., Hill, R. L. R., Elborn, J. S. & McMullan, R., 12 May 2014.

Research output: Contribution to conferencePaper

16 Citations (Scopus)
113 Downloads (Pure)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis

Kenny, S. L., Shaw, T. D., Downey, D. G., Moore, J. E., Rendall, J. C. & Elborn, J. S., Aug 2014, In : BMJ Open Respiratory Research. 1, p. 1-7 e000021.

Research output: Contribution to journalArticle

Open Access
File
Cystic Fibrosis
Pseudomonas aeruginosa
Anti-Bacterial Agents
Ciprofloxacin
Infection